kringle-pharmaCo., Ltd.

NEWS

notice

Jan 28, 2009 Notice

Kringle Pharma Commences a Phase I/II Clinical Trial in Sweden on ChronSeal, a Recombinant Human HGF-Based Therapy for the Treatment of Skin Ulcers.

Kringle Pharma Commences a Phase I/II Clinical Trial in Sweden on ChronSeal®, a Recombinant Human HGF-Based Therapy for the Treatment of Skin Ulcers.